T cell Selection for Adoptive Cell therapy: A Deep Dive in Cancer Immunotherapy Targets

When:  Jan 25, 2022 from 11:30 to 13:30 (ET)

The Society for Immunotherapy of Cancer (SITC) is pleased to offer a highly anticipated series of eight, online seminars to address key questions in the field of cancer immunotherapy, both in-depth and in an easily accessible format. "T cell Selection for Adoptive Cell therapy: A Deep Dive in Cancer Immunotherapy Targets" is the eighth seminar in the series.

Co-chairs
:

  • Cara Haymaker, PhD – The University of Texas MD Anderson Cancer Center
  • Cassian Yee, MD – The University of Texas MD Anderson Cancer Center

Faculty:

  • Marcela V. Maus, MD, PhD – Massachusetts General Hospital
  • Chrystal M. Paulos, PhD – Winship Cancer Institute at Emory University
  • Stanley R. Riddell, MD – Fred Hutchinson Cancer Research Center

Seminar agenda:

  • 11:30-11:35 am ET: Welcome and Introductions
  • 11:35-12:50 pm ET: Faculty Presentations
  • 12:50-1:20 pm ET: Question and Answer Session
  • 1:20-1:30 pm ET: Closing Remarks

Targets for Cancer Immunotherapy: A Deep Dive Seminar Series is supported, in part, by grants from Alkermes, Inc., Genentech, a member of the Roche Group, Incyte Corporation, Merck & Co., Inc., and Regeneron Pharmaceuticals (as of 10/05/2021).